Acute Coronary Syndrome admissions and outcome during COVID-19 Pandemic–Report from large tertiary centre in India

Showkathali, Refai; Yalamanchi, Radhapriya; Sankeerthana, M.P.; Kumaran, Selva Nandha; Shree, Suvetha; Nayak, Rajeshwari; Oomman, Abraham; Mahilmaran, Asha

doi:10.1016/j.ihj.2020.09.005

Cited by 17 publications

(22 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several centres have reported a decrease in admissions during the pandemic, 1,2,6 whereas others have found no significant difference compared with pre-COVID-19 levels. 5 With regard to the type of MI, most studies have shown a decrease in NSTEMI admissions during the COVID-19 pandemic, but mixed results pertaining to STEMI presentations.…”

Section: Discussionmentioning

confidence: 95%

“…This is in keeping with reports from other studies, and is testament to the robustness of these medical systems in maintaining a high level of cardiovascular care despite the pandemic. 1,6,14 Data on PCI volumes provide some insights into how COVID-19 has affected elective procedures. The decrease in PCI in the present study was driven largely by data from Singapore, where there was an active push to reschedule non-urgent elective cardiac catheterisation.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Impact of COVID-19 on Acute MI and Percutaneous Coronary Intervention Rates and Outcomes in South East Asia and the Middle East

Tern

Jiang

Lau

et al. 2022

J Asian Pac Soc Cardiol

View full text Add to dashboard Cite

Background: Previous studies have reported mixed findings regarding the effects of COVID-19 on percutaneous coronary intervention (PCI) and acute MI (AMI) procedural volumes and case fatalities, as well as on ST-elevation MI (STEMI) door-to-balloon time (DTB). This study characterised the effects of COVID-19 on AMI and PCI volumes and mortality outcomes in countries from Asia and the Middle East, which faced repeated waves of COVID-19. Methods: Pooled data on AMI and PCI case volumes were collected in 4-weekly blocks from Malaysia, Singapore and Abu Dhabi from 2019 (pre-COVID-19) and 2020 (during COVID-19). These were compared against reported COVID-19 case numbers. Case fatality rates, STEMI patient demographics and STEMI DTB times were compared between the pre- and during COVID-19 periods. Results: During the COVID-19 pandemic, there was a comparative reduction in non-STEMI (NSTEMI) cases in Singapore (from 814 to 722; p=0.025) and Malaysia (from 925 to 604; p<0.001), but not in Abu Dhabi (from 144 to 188; p=0.010). PCI volumes fell significantly in Singapore (from 13,089 to 11,449; p=0.020), but not in Malaysia or Abu Dhabi. STEMI volume remained similar before and during COVID-19. There were no significant differences in in-hospital mortality for NSTEMI, STEMI or PCI between the two periods. Conclusion: COVID-19 resulted in a fall in NSTEMI and PCI cases, potentially as a result of patients deferring contact with healthcare institutions. With appropriate protocols and systems, it is possible to provide coronary intervention services in the middle of a pandemic without compromising on mortality or DTB outcomes.

show abstract

Section: Discussionmentioning

confidence: 95%

Section: Discussionmentioning

confidence: 99%

Impact of COVID-19 on Acute MI and Percutaneous Coronary Intervention Rates and Outcomes in South East Asia and the Middle East

Tern

Jiang

Lau

et al. 2022

J Asian Pac Soc Cardiol

View full text Add to dashboard Cite

show abstract

“…Admissions for acute coronary syndrome (ACS) had decreased significantly by more than one third over three months in India since the lockdown. 31 , 32 There was greater reductions in the number of NSTEMI than STEMI. The decrease in the hospitalisations corroborated with the lockdown and the difference in the rates lessened in the second phase of lockdown.…”

Section: Covid-19 Pandemic and Cardiovascular Carementioning

confidence: 97%

COVID 19 pandemic: Its impact on cardiovascular training and care

Guha¹,

Karak²,

Choudhury³

et al. 2020

Indian Heart Journal

View full text Add to dashboard Cite

“…In a hospital located in Hong Kong, delays in performing percutaneous coronary interventions for patients who visited an emergency department for acute myocardial infarction (AMI) were reported (Lotfi et al, 2020). A study from India also observes reduced cases of AMI patients and deterioration in patient outcomes (Showkathali et al, 2020). Care for nonacute conditions also decreased during the pandemic.…”

Section: Indirect Effects Of the Covid-19 Pandemicmentioning

confidence: 99%

Health and Public Health Implications of COVID‐19 in Asian Countries

Miyawaki

2021

Asian Economic Policy Review

View full text Add to dashboard Cite

This paper discusses the impacts of the COVID-19 pandemic on population health in Asian countries. Compared to European countries, Asian countries, in general, experienced much fewer COVID-19 cases and deaths. The underlying factors in this difference would include the earlier and more stringent nonpharmaceutical interventions, differences in the age structure, the geographical characteristics in Asia, and the experience of past outbreaks of emerging diseases, though further studies are needed to investigate the exact mechanisms. Still, regarding the aim of developing resilient health care systems, there remain several lessons from the COVID-19 pandemic experience in Asian countries that could inform more effective management of future pandemics.

show abstract

Acute Coronary Syndrome admissions and outcome during COVID-19 Pandemic–Report from large tertiary centre in India

Cited by 17 publications

References 14 publications

Impact of COVID-19 on Acute MI and Percutaneous Coronary Intervention Rates and Outcomes in South East Asia and the Middle East

Impact of COVID-19 on Acute MI and Percutaneous Coronary Intervention Rates and Outcomes in South East Asia and the Middle East

COVID 19 pandemic: Its impact on cardiovascular training and care

Health and Public Health Implications of COVID‐19 in Asian Countries

Contact Info

Product

Resources

About